featured
Ribociclib for the Treatment of HR+, HER2− Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Expert Review of Anticancer Therapy
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ribociclib for the Treatment of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
Expert Rev Anticancer Ther 2018 Mar 01;18(3)201-213, HA BurrisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.